Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Effect on PSA Doubling Time in Prostate Cancer
NCT02176161Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2014
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in prostate cancer (PCa), sponsored by NYU Langone Health. Started Jun 2014; status: completed.
02
Drugs
metformin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02176161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176161.